GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr 。#抗生素# $葛兰素史克(GSK)$ $Spero治疗(SPRO)$
| 发布于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr 。#抗生素# $葛兰素史克(GSK)$ $Spero治疗(SPRO)$